Actor
Anokion SA
Develops antigen-specific immune tolerance technology to reduce the immunogenicity of therapeutic proteins and treat autoimmune diseases.
Specialties
Primary Therapeutic Areas
1.0 Therapeutic & Diagnostic
1.00 Antibodies & Anti-infectious
1.09 Proteins & Peptides
Business model
1. Entreprise
1.1 Start-Up
Organization Type
Private Company
Visit website
Domains
Cardiovascular & Hematology, Immunology & Allergy
Main sector
Biotech
Contact
EPFL Innovation Park Building L
1024 Ecublens / VD